PLAT and Thrombocytopenia: Use of ILV could possibly decrease the need for more costly, invasive, and morbid strategies such as ECMO, especially in scenarios where such pathways are unavailable (limited expertise or resources) or contraindicated (profound thrombocytopenia, disseminated intravascular coagulation, recent tPA use).